Cassava Sciences' controversial Alzheimer's drug fails in second late-stage study

Quelle surprise (non quand on suit le travail de @elisabethbik.bsky.social on savait que c'était biteux).

https://www.reuters.com/business/healthcare-pharmaceuticals/cassava-discontinue-development-alzheimers-disease-drug-2025-03-25/

Comments

Posting Rules

  • Be respectful to others
  • No spam or self-promotion
  • Stay on topic
  • Follow Bluesky's terms of service